Penn State Hershey Cancer Center is a clinical research site located in Hershey, Pennsylvania, United States 17033.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
Penn State Hershey Cancer Center has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma, Metastatic Pancreatic Cancer.
Sponsors: Ono Pharmaceutical Co. Ltd, Momenta Pharmaceuticals, Inc., Baxalta now part of Shire.
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Penn State Hershey Cancer Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Penn State Hershey Cancer Center has 4 clinical trials on record, with 1 currently active. Their work covers Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma, Metastatic Pancreatic Cancer.
Penn State Hershey Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.